SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sac Capital Associates LLC – ‘4’ for 1/7/03 re: Oncogenex Pharmaceuticals, Inc.

On:  Tuesday, 1/7/03, at 4:25pm ET   ·   For:  1/7/03   ·   Accession #:  899140-3-23   ·   File #:  0-21243

Previous ‘4’:  ‘4’ on / for 11/27/02   ·   Next:  ‘4’ on 8/22/03 for 8/11/03   ·   Latest:  ‘4’ on 2/24/10 for 2/23/10

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/07/03  Sac Capital Associates LLC        4          10% Owner   1:8K   Sonus Pharmaceuticals Inc.        Willkie Fa… Gallagher/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of        2     15K 
                Securities by an Insider                                         

41st Page of 2TOCTopPreviousNextBottomJust 1st
 

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ________________________________________________________________________________ 1. Name and Address of Reporting Person* S.A.C. Capital Associates, LLC -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o 72 Cummings Point Road -------------------------------------------------------------------------------- (Street) Stamford CT 06902 -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol Sonus Pharmaceuticals ("SNUS") ________________________________________________________________________________ 3. IRS Identification Number of Reporting Person, if an entity (Voluntary) ________________________________________________________________________________ 4. Statement for Month/Day/Year 1/7/2003 ________________________________________________________________________________ 5. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [X] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ------------------------ ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check applicable line) [X] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person ________________________________________________________________________________ ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================ [Enlarge/Download Table] 5. Amount of 6. 4. Securities Owner- 2. 2A. 3. Securities Acquired (A) or Beneficially ship Trans- Deemed Trans- Disposed of (D) Owned Form: 7. action Execution action (Instr. 3, 4 and 5) Following Direct Nature of Date Date, if any Code ----------------------------- Reported (D) or Indirect 1. (Month/ (Month/ (Instr. 8) (A) Transaction(s) Indirect Beneficial Title of Security Day/ Day/ ---------- Amount or Price (Instr. 3 (I) Ownership (Instr. 3) Year) Year) Code V (D) and 4) (Instr.4) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par 1/3/03 P 16,300 A $2.0906 1,052,376 D value $0.001 per share ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v). Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 1 of 2
4Last Page of 2TOC1stPreviousNextBottomJust 2nd
FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================ [Enlarge/Download Table] 5. 7. Number of Title and Amount Derivative 6. of Underlying 4. Securities Date Securities 2. 3A. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) Conver- Deemed action or Disposed Expiration Date ---------------- 1. sion or 3. Execution Code of(D) (Month/Day/Year) Amount Title of Exercise Trans- Date, (Instr. (Instr. 3, ---------------- or Derivative Price of action Date if any 8) 4 and 5) Date Expira- Number Security Derivative (Month/ (Month/ ------ ------------ Exer- tion of (Instr. 3) Security Day/Year) Day/Year) Code V (A) (D) cisable Date Title Shares ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== [TABLE CONTINUED BELOW] [CONTINUATION OF TABLE FROM ABOVE] [Enlarge/Download Table] 9. Number of 10. Derivative Ownership Securities Form of 11. 8. Beneficially Derivative Nature Price of Owned Follow- Security of Indirect Derivative ing Reported Direct (D) or Beneficial Security Transaction(s) Indirect (I) Ownership (Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4) --------------------------------------------------------- --------------------------------------------------------- ========================================================= Explanation of Responses: /s/ Peter Nussbaum January 7, 2003 --------------------------------------------- ----------------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 2 of 2

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘4’ Filing    Date First  Last      Other Filings
Filed on / For Period end:1/7/0324
 List all Filings 
Top
Filing Submission 0000899140-03-000023   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 10:03:20.1pm ET